←Back to Expert Scholars
Translational Medicine / 转化医学Pan RAS Inhibitors
Channing Der
PhD
🏢University of North Carolina Chapel Hill🌐USA
Kenan Distinguished Professor
120
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Channing Der is a pioneer of RAS signaling research and has contributed fundamental insights into RAS biology and therapeutic targeting. His work supports the development of pan RAS and isoform selective inhibitors and rational combinations. He continues to guide drug discovery efforts against RAS driven cancers.
Share:
🧪Research Fields 研究领域
RAS
signal transduction
pancreatic cancer
drug discovery
autophagy
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Channing Der 的研究动态
Follow Channing Der's research updates
留下邮箱，当我们发布与 Channing Der（University of North Carolina Chapel Hill）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment